Company Name: Acceleron Pharma Inc.
Acceleron Pharma Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of therapeutic candidates designed to regulate cellular growth and repair with a focus on the transforming growth factor-beta (TGF-beta) protein superfamily.
Ticker Symbol: XLRN (NASDAQ)
Company Website: www.acceleronpharma.com
Headquarters: Cambridge, MA